BioGaia AB (publ) (BGLA.F)

10,60 +0,01 (+0,09%) Ab 08:05AM CEST. Markt geöffnet.

BioGaia AB (publ)

Kungsbroplan 3
Stockholm
Sweden
46 8 555 293 00
https://www.biogaia.com

Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 210

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Peter Rothschild M.Sc. Econ., MBA	Founder & Chairman	1,33M	N/A	1950
Ms. Theresa P. Agnew	CEO & President	6,75M	N/A	1966
Mr. Alexander Kotsinas M.Sc. (Eng.).	Executive VP & CFO	3,07M	N/A	1967
Ludvig Milesson	Chief Operating Officer	N/A	N/A	1977
Mr. Gianfranco Grompone	Chief Scientific Officer and VP of Research & Development	N/A	N/A	1975
Ms. Caroline Mofors	Chief Legal Officer	N/A	N/A	1972
Ms. Linda Hagglund	Vice President of Marketing	N/A	N/A	1973
Ms. Angelika Kjelldorff	Chief HR Officer	N/A	N/A	1969
Sebastian Heimfors	VP & Chief Commercial Officer	N/A	N/A	1974
Jonathan Gromark	Sustainability Manager	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.

Corporate Governance

BioGaia AB (publ)s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 10. Die grundlegenden Scores sind Audit: 10, Vorstand: 9, Shareholderrechte: 8, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.